More than 270 million people worldwide cannot be free to live in dusty environments due to the increasingly common dust mite allergy. Dust.IN is creating a new generation of drugs to inhibit dust mite allergies. The company will develop compounds that act by blocking the sites of dust mite proteins responsible for the life-threatening symptoms caused in humans. This new attitude towards allergy will 'attack' directly the allergic agent before triggering any human body's response. Dust.IN will definitely bring fresh air into dust mite allergy! Is this the end of vacuum cleaners?

Henrique Martins
Ana C.A. Roque